FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076607003> ?p ?o ?g. }

• W2076607003 endingPage "1565" @default.
• W2076607003 startingPage "1557" @default.
• W2076607003 abstract "Three major glaucoma trials, all using the same Humphrey visual field tests, specified different criteria to define visual field progression. This article compares the performance of these criteria with a reference standard of unanimous classifications by 3 independent glaucoma experts.Longitudinal, comparative study of diagnostic criteria.Two hundred forty-five patients with manifest glaucoma in the Early Manifest Glaucoma Trial (EMGT).Visual field series of 1 eye of each of 245 EMGT patients were classified by 3 independent glaucoma specialists as definitely progressing, definitely nonprogressing, or neither. Field series that were classified in the first 2 categories by all 3 experts met the reference standards for the progressing and nonprogressing groups and were analyzed according to the progression criteria of the Advanced Glaucoma Intervention Study (AGIS), the Collaborative Initial Glaucoma Treatment Study (CIGTS), and the EMGT. Sensitivity, specificity, time to progression, and sustainability were calculated.Progression, nonprogression, sensitivity, specificity, time to progression, and sustainability.Seventy-seven field series were definitely progressing, and 95 series were definitely nonprogressing. Among progressing eyes, 45 (58%) of 77 were identified using AGIS criteria, 58 (75%) of 77 were identified with CIGTS criteria, and 74 (96%) of 77 were identified with EMGT criteria; all comparisons of sensitivities were significant, simultaneous (P<0.001), and pairwise (P<0.01). The specificity for EMGT criteria was 89%, lower (P<0.05) than that of AGIS (98%) and CIGTS (99%) criteria. Median time to progression was considerably shorter with EMGT criteria (33 months; 95% confidence interval [CI], 30-36 months) than with AGIS (66 months; 95% CI, 57-78 months) and CIGTS (55 months; 95% CI, 48-66 months) criteria. Sustainability increased with time after progression; it averaged 79%, 84%, and 81%, respectively, for AGIS, CIGTS, and EMGT criteria during the first year after the first progression and 95%, 100%, and 93% during the fourth year after progression.The EMGT criteria identified progression earlier and more often than AGIS and CIGTS criteria. Specificity was good for all criteria but was better with AGIS and CIGTS than with EMGT criteria. Sustainability was high for all 3 sets of criteria and best for CIGTS criteria and increased with time after progression." @default.
• W2076607003 created "2016-06-24" @default.
• W2076607003 creator A5001220960 @default.
• W2076607003 creator A5022617905 @default.
• W2076607003 creator A5030249716 @default.
• W2076607003 creator A5042154148 @default.
• W2076607003 creator A5061354972 @default.
• W2076607003 creator A5067964100 @default.
• W2076607003 creator A5077955591 @default.
• W2076607003 date "2008-09-01" @default.
• W2076607003 modified "2023-10-14" @default.
• W2076607003 title "A Comparison of Visual Field Progression Criteria of 3 Major Glaucoma Trials in Early Manifest Glaucoma Trial Patients" @default.
• W2076607003 cites W1973720349 @default.
• W2076607003 cites W1982226559 @default.
• W2076607003 cites W2007611245 @default.
• W2076607003 cites W2011481648 @default.
• W2076607003 cites W2014539110 @default.
• W2076607003 cites W2020396326 @default.
• W2076607003 cites W2026209674 @default.
• W2076607003 cites W2029017535 @default.
• W2076607003 cites W2035819222 @default.
• W2076607003 cites W2056439508 @default.
• W2076607003 cites W2061841032 @default.
• W2076607003 cites W2084413241 @default.
• W2076607003 cites W2094553388 @default.
• W2076607003 cites W2094803132 @default.
• W2076607003 cites W2097220938 @default.
• W2076607003 cites W2107476882 @default.
• W2076607003 cites W2147093603 @default.
• W2076607003 cites W2148890166 @default.
• W2076607003 cites W2157134953 @default.
• W2076607003 cites W2164777277 @default.
• W2076607003 cites W2616044243 @default.
• W2076607003 cites W4242563711 @default.
• W2076607003 doi "https://doi.org/10.1016/j.ophtha.2008.02.005" @default.
• W2076607003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18378317" @default.
• W2076607003 hasPublicationYear "2008" @default.
• W2076607003 type Work @default.
• W2076607003 sameAs 2076607003 @default.
• W2076607003 citedByCount "115" @default.
• W2076607003 countsByYear W20766070032012 @default.
• W2076607003 countsByYear W20766070032013 @default.
• W2076607003 countsByYear W20766070032014 @default.
• W2076607003 countsByYear W20766070032015 @default.
• W2076607003 countsByYear W20766070032016 @default.
• W2076607003 countsByYear W20766070032017 @default.
• W2076607003 countsByYear W20766070032018 @default.
• W2076607003 countsByYear W20766070032019 @default.
• W2076607003 countsByYear W20766070032020 @default.
• W2076607003 countsByYear W20766070032021 @default.
• W2076607003 countsByYear W20766070032022 @default.
• W2076607003 countsByYear W20766070032023 @default.
• W2076607003 crossrefType "journal-article" @default.
• W2076607003 hasAuthorship W2076607003A5001220960 @default.
• W2076607003 hasAuthorship W2076607003A5022617905 @default.
• W2076607003 hasAuthorship W2076607003A5030249716 @default.
• W2076607003 hasAuthorship W2076607003A5042154148 @default.
• W2076607003 hasAuthorship W2076607003A5061354972 @default.
• W2076607003 hasAuthorship W2076607003A5067964100 @default.
• W2076607003 hasAuthorship W2076607003A5077955591 @default.
• W2076607003 hasConcept C118487528 @default.
• W2076607003 hasConcept C126322002 @default.
• W2076607003 hasConcept C141071460 @default.
• W2076607003 hasConcept C168563851 @default.
• W2076607003 hasConcept C2776058522 @default.
• W2076607003 hasConcept C2778527774 @default.
• W2076607003 hasConcept C44249647 @default.
• W2076607003 hasConcept C535046627 @default.
• W2076607003 hasConcept C71924100 @default.
• W2076607003 hasConceptScore W2076607003C118487528 @default.
• W2076607003 hasConceptScore W2076607003C126322002 @default.
• W2076607003 hasConceptScore W2076607003C141071460 @default.
• W2076607003 hasConceptScore W2076607003C168563851 @default.
• W2076607003 hasConceptScore W2076607003C2776058522 @default.
• W2076607003 hasConceptScore W2076607003C2778527774 @default.
• W2076607003 hasConceptScore W2076607003C44249647 @default.
• W2076607003 hasConceptScore W2076607003C535046627 @default.
• W2076607003 hasConceptScore W2076607003C71924100 @default.
• W2076607003 hasIssue "9" @default.
• W2076607003 hasLocation W20766070031 @default.
• W2076607003 hasLocation W20766070032 @default.
• W2076607003 hasOpenAccess W2076607003 @default.
• W2076607003 hasPrimaryLocation W20766070031 @default.
• W2076607003 hasRelatedWork W2058371815 @default.
• W2076607003 hasRelatedWork W2062030628 @default.
• W2076607003 hasRelatedWork W2075211857 @default.
• W2076607003 hasRelatedWork W2155214832 @default.
• W2076607003 hasRelatedWork W2350923514 @default.
• W2076607003 hasRelatedWork W3028891078 @default.
• W2076607003 hasRelatedWork W3039628006 @default.
• W2076607003 hasRelatedWork W3137518859 @default.
• W2076607003 hasRelatedWork W4361304460 @default.
• W2076607003 hasRelatedWork W77622534 @default.
• W2076607003 hasVolume "115" @default.
• W2076607003 isParatext "false" @default.
• W2076607003 isRetracted "false" @default.
• W2076607003 magId "2076607003" @default.
• W2076607003 workType "article" @default.